Introduction {#S1}
============

Heat shock proteins (HSPs) function as molecular chaperones, thereby assisting protein folding, and non-covalent assembly or disassembly of macromolecules ([@B90]). HSPs are structurally related proteins and classified based on their molecular weights, ranging from 10 to \>100 kDa ([@B37]). HSP subfamily members exert similar functions across species. For example, small HSPs (HspB1 to HspB10) prevent the aggregation of misfolded proteins in an ATP-independent manner ([@B2]). ATP-dependent chaperones include Hsp60, Hsp70, and Hsp90. Hsp60 assists protein refolding throughout transport from the cytoplasm to the mitochondrial matrix ([@B16]), while Hsp70 exerts the anti-aggregation activity with co-chaperones Hsp40 or Hsp110 ([@B40]). Hsp40 presents unfolded proteins to Hsp70 and stimulates its ATP hydrolysis ([@B4]). Hsp90 regulates assembling, refolding and stabilizing of substrate proteins ([@B86]). HSPs function in a wide range of cellular processes to maintain protein homeostasis under physiological conditions and in response to environmental stresses ([@B33]).

Invasion of pathogens, such as bacteria or viruses, may trigger cell stress responses and hence induces the production of cellular HSPs. Various viruses take advantage of cellular HSPs to overcome host environmental challenges and complete their infectious cycles ([@B60]). HSPs may participate in distinct steps during infection processes, such as viral entry, replication, and viral particle assembly and movement ([Table 1](#T1){ref-type="table"}). It is noteworthy that dengue virus particularly utilizes a set of Hsp70 family members for its entry, RNA replication and virion production ([@B79]). Moreover, some of the HSPs, particularly Hsp70, even become an integral component of virions ([@B72]). All these findings emphasize the importance of HSPs in viral infection.

###### 

Function of the HSP-virus interaction.

  **HSP family**   **Member**            **Virus**   **Interacting viral proteins**   **Engrave roles in HSP-virus interaction**                              **References**
  ---------------- --------------------- ----------- -------------------------------- ----------------------------------------------------------------------- ----------------
  Hsp40            DNAJA1, DNAJB1        IAV         NP, PB2, PA                      Enhance nuclear import of vRNP complex and viral RNA synthesis          [@B15]; [@B7]
                   DNAJA2                HCV         NS5A                             NS5A-mediated IRES translation                                          [@B25]
  Hsp60            HSPD                  HBV         HBx                              Enhance HBx-induced apoptosis and HBx protein folding                   [@B82]; [@B92]
                                                     Virus polymerase                 Enhance viral polymerase activity                                       [@B63]
  Hsp70            HSPA1A                HIV         Virion                           Virion assembly                                                         [@B26]
                   HSPA1A                MuV         P protein                        Facilitate IBs formation and modulate degradation of P protein          [@B41]
                   HSPA1A                HCV         NS5A                             NS5A-mediated IRES translation                                          [@B25]
                   HSPA1, HSPA2, HSPA8   KSHV        RTCs                             Facilitate RTCs formation and nuclear import                            [@B3]
                   HSPA5                 RSV         Viral IBs                        Enhance viral polymerase activity                                       [@B14]
                   HSPA9                 HBV         HBx                              Viral protein folding                                                   [@B92]
  Hsp90            HSP90AA1, HSP90AB1    IAV         PB1, PB2                         Facilitate vRNP stabilization and nuclear import, viral RNA synthesis   [@B58]; [@B59]
                   HSP90AA1              Rotavirus   NSP3                             Viral protein folding and stabilization                                 [@B24]
                   HSP90A                RSV         Viral filaments and IBs          Viral particle assembly                                                 [@B67]
                   HSP90                 MuV         L protein                        Viral protein stabilization                                             [@B42]
                   HSP90                 HCV         NS3                              Viral protein stabilization                                             [@B84]

IAV, influenza A virus; NP, nucleoprotein; vRNP, viral ribonucleoprotein complex; PB2, polymerase basic protein 2; PB1, polymerase basic protein 1; PA, polymerase acidic protein; HCV, hepatitis C virus; NS5A, non-structural 5A protein; HBV, hepatitis B virus; HBx, hepatitis B virus X protein; HIV, human immunodeficiency virus; MuV, mumps virus; P protein, phophoprotein; KSHV, kaposi's sarcoma-associated herpes virus; RTCs, replication and transcription compartments; RSV, respiratory syncytial virus; IBs, inclusion bodies; NSP3, non-structural protein 3; L protein, large protein; NS3, non-structural protein 3.

Heat shock proteins may also negatively impact viral infection. For example, two Hsp40 members inhibit the replication of human hepatitis B virus (HBV) ([@B77]). Hsp70 interferes with nuclear import of the human immunodeficiency viruses (HIV) preinitiation complex, and viral gene expression and replication ([@B45]). In addition, HSPs have immunomodulatory roles, although opposing. HSPs may act as a pro-inflammatory molecule by facilitating pathogenic antigen presentation on the antigen-presenting cells ([@B9]). On the other hand, HSPs may prevent immune activation by reducing inflammatory damages and promoting anti-inflammatory cytokines production ([@B30]; [@B13]). Together, HSPs are engaged in both host immune response and viral pathogenesis during infection.

The MRJ Protein and Its Functional Domains {#S2}
==========================================

Mammalian relative of DnaJ (MRJ/DNAJB6) is an Hsp40 family member. The Hsp40 family can be categorized into three major types (I, II, and III), all of which share the ∼70-amino acid J-domain ([@B49]; [Figure 1A](#F1){ref-type="fig"}). In type-I Hsp40 proteins, the J-domain is at the N-terminus, followed by the glycine/phenylalanine (G/F)-rich region, the zinc finger domain, and the peptide-binding domain in the C-terminus. Type-II is similar to type-I but lacks a zinc finger domain. Type-III members contain only the J-domain, whose location differs between members ([@B66]). Many, but not all, Hsp40 members act as cochaperones of Hsp70 by forming a heterodimer through the J-domain ([@B47]; [@B55]; [@B48]). The J-domain of Hsp40 containing the invariant histidine-proline-aspartic acid (HPD) tripeptide stimulates the ATPase activity of Hsp70 and increases the affinity of Hsp70 for the polypeptide substrate released from Hsp40 ([@B78]). The G/F-rich region of MRJ contains several hydrophobic residues responsible for substrate recognition; phenylalanine mutations disrupt its anti-aggregation activity ([@B73]; [@B62]). The C-terminal part of MRJ contains a serine/threonine (S/T)-rich region, which is important for substrate binding ([@B39]). Nevertheless, Hsp40s bind and transfer non-native polypeptides to Hsp70 through distinct mechanisms, which are subject to further processing ([@B78]). In addition, the C-terminal region of MRJ is also involved in polydisperse oligomeric complexes and oligomerization ([@B27]; [Figure 1B](#F1){ref-type="fig"}, protein). All these functional domains are present in both splice isoforms of MRJ (see below).

![Human MRJ gene and functions in the viral life cycle. **(A)** Schematic diagram of three major types of Hsp40. All contain the J-domain. The J-domain is located at the N-terminus of type I and II Hsp40 but is found at various locations within the type III members. Additional domains are as depicted. **(B)** Schematic diagram (upper) shows genomic organization of the human MRJ gene and its transcript isoforms that are generated by alternative splicing and polyadenylation. A reduction in the CstF64 level in macrophages favors MRJ-L production. A morpholino oligonucleotide targeting the 5' splice site of intron 8 suppresses (MRJ-L expression. The bottom schematic diagram shows three major domains of the MRJ protein, including the J-domain followed by the G/F-rich domain in the N-terminal part, and the C-terminal peptide-binding domain, which interacts with denatured polypeptides and also directs the function of Hsp70. The conserved HPD motif of the J-domain, the SSF and SST motifs (namely the S/T-rich region) in the C-terminal peptide-binding domain and LGMD-associated mutations in the G/F domain are indicated. MRJ-S has a truncated C-terminal domain that lacks the NLS. **(C)** The two MRJ isoforms participate in the infection of the following viruses. HIV, MRJ-L facilitates nuclear import of the PIC via its interaction with Vpr (HIV-1) or Vpx (HIV-2), and hence facilitates the integration of the HIV genome into host chromosomes. HCMV, MRJ-L interacts with the DNA polymerase UL70 of HCMV and facilitates its nuclear import so that MRJ-L enhances viral genome synthesis. RSV, MRJ-L is essential for the expression of viral mRNAs and proteins, and viral production, but how it functions remains yet unclear. DENV: DENV replicates its genomes released from the pore of DENV-induced vesicle-like structures. The newly synthesized genome is packaged in the nucleocapsid with the capsid protein, which subsequently buds form proximal ER membranes. MRJ-S is colocalized with the viral capsid protein on the LD surface and facilitates viral assembly. Assembled viruses are transported to the Golgi apparatus for the maturation processes.)](fmicb-10-02885-g001){#F1}

Regulation of MRJ Isoform Expression {#S3}
====================================

MRJ is ubiquitously expressed in human tissues, with a higher level in the brain ([@B19]). MRJ is upregulated during mitosis in HeLa cells perhaps to support mitotic activities ([@B22]). Human *MRJ* has two splice isoforms, *MRJ-L* and *MRJ-S*, generated through alternative splicing ([@B28]). The *MRJ* gene has ten exons. The first eight exons are included in both isoforms, while the last two exons are missing in *MRJ-S* ([@B44]; [Figure 1B](#F1){ref-type="fig"}, mRNA). MRJ-L and MRJ-S proteins are comprised of 326 and 241 amino acid residues, respectively; both possess the aforementioned three functional domains. MRJ-L has a nuclear localization signal (NLS) in its very C-terminal region. Suppression of splicing in conjunction with activation of aberrant polyadenylation signals in intron 8 leads to *MRJ-S* expression. *MRJ* has been identified as a potential target transcript of cleavage stimulation factor subunit 2 (CstF64/CSTF2), a cleavage stimulation factor for mRNA 3'-end processing ([@B91]). Knockdown or overexpression of CstF64, respectively, increases and decreases the L/S isoform ratio ([@B44]). A decline in the CstF64 level during macrophage differentiation favors *MRJ-L* expression ([Figure 1B](#F1){ref-type="fig"}, mRNA). In addition, serine/arginine-rich splicing factor 3 (SRSF3) may promote *MRJ-S* expression ([@B44]). Cyclin-dependent kinase 12 (CDK12) amplification in breast cancer results in downregulation of *MRJ-L* via modulating its terminal exon selection ([@B83]). Thus, the *MRJ* isoform ratio may be modulated in response to different cellular signals. Moreover, *MRJ-L* expression can be enhanced by increasing the strength of the 5' splice site of intron 8. Single nucleotide variations in the proximal polyadenylation signal and the polypyrimidine tract of intron 8 also affect *MRJ* isoform ratios. Thus, both alternative splicing and alternative polyadenylation activities determine *MRJ* isoform expression ([@B44]).

Cellular Functions of MRJ {#S4}
=========================

*MRJ* knockout mice show embryonic lethality due in part to placental abnormalities and neural tube defects ([@B34]; [@B89]). MRJ is involved in a variety of physiological processes, from transcription, cellular signaling to cell adhesion. MRJ suppresses the transcriptional activity of nuclear factors of activated T-cells (NFAT) by recruiting class II histone deacetylases, and hence, reduces calcineurin-induced cardiac myocyte growth. This observation suggests a role of MRJ in preventing cardiac hypertrophy ([@B20]). More notably, MRJ suppresses Wnt/β-catenin signaling through multiple pathways. Essentially, MRJ upregulates the secretary glycoprotein and Wnt inhibitor dickkopf 1 (DKK1) and maintains the dephosphorylation status of glycogen synthase kinase 3β (GSK3β) through the protein phosphatase PP2A and hence promotes degradation of β-catenin ([@B56]). This suppressive effect of MRJ on Wnt-β-catenin signaling negatively regulates tumor growth and metastases. Accordingly, a reduction of the MRJ level is present in various invasive and metastatic cancers as earlier mentioned. On the other hand, MRJ influences cytoskeletal organization, which is responsible for cell growth, division, and migration. For example, MRJ modulates intermediate filament organization via its direct interaction with keratins ([@B36]). *MRJ* knockout causes actin cytoskeletal collapse in chorionic trophoblast cells ([@B88]). MRJ also contributes to cell adhesion and migration via its interaction with urokinase-type plasminogen activator receptor (uPAR) ([@B21]; [@B51]). A recent report reveals that MRJ promotes spindle pole focusing via its interaction with dynactin, which is essential for chromosome segregation during cell division ([@B69]).

Pathological Effects of Defective MRJ {#S5}
=====================================

Genetic mutations or dysfunction of MRJ have been observed in human diseases such as limb-girdle muscular dystrophy (LGMD), myopathy and neurodegenerative diseases. Phenylalanine mutations in the (G/F)-rich region of MRJ are found in LGMD and distal myopathy, indicating that the chaperone activity of MRJ is critical for preventing proteinopathy ([@B29]; [@B73]; [@B50]; [@B38]). MRJ mutations result in myofibrillar aggregates containing ubiquitin, ubiquitin-binding protein p62 and TAR DNA-binding protein 43 (TDP-43) ([@B74]; [@B71]). Notably, TDP-43 aggregation is a characteristics of amyotrophic lateral sclerosis ([@B81]), emphasizing the pathological effect of defective MRJ in neurodegenerative disorders. The C-terminal S/T-rich region in MRJ exhibits the suppressive effect on the formation of different aggregation-prone peptides such as amyloid-β and polyglutamine peptides that are involved in the pathogenesis of Alzheimer's disease and Huntington's disease, respectively ([@B39]; [@B53]; [@B5]). MRJ has also been implicated in Parkinson's disease. Upregulation of MRJ in parkinsonian astrocytes prevents the neuronal release of α-synuclein/SNCA, which has the potential to form toxic aggregates, suggesting a protective role of MRJ ([@B23]; [@B1]). A more recent study indicates that the chaperone activity of MRJ also suppresses mutant parkin aggregation ([@B39]). Thus, it is likely that the chaperone function of MRJ contributes to preventing protein misfolding in neurodegenerative diseases.

Role of MRJ in Virus Infection {#S6}
==============================

In addition to the cellular functions above mentioned, both MRJ isoforms have been implicated in infection and pathogenesis of multiple human viruses. A recent report unveils the involvement of a translocon complex factor, Sec61, in the biogenesis of several different viral proteins, suggesting that targeting Sec61 can provide an antiviral strategy against multiple viruses ([@B31]). In light of this finding, we review the roles of MRJ in infection and propagation of several viruses and discuss the potential of targeting MRJ as an antiviral strategy.

Human Immunodeficiency Viruses (HIV) {#S6.SS1}
------------------------------------

Human immunodeficiency viruses is a retrovirus that causes acquired immunodeficiency syndrome (AIDS), which destroys the immune system of infections ([@B75]). HIV infects macrophages and CD4^+^ T helper cells through the CD4 receptor and its coreceptor, i.e., chemokine receptor CCR5 or CXCR4 ([@B52]). After infection, HIV is integrated into the human genome, which is essential for the viral life cycle ([@B57]). For integration, HIV establishes the pre-integration complex (PIC), consisting of the cDNA that is converted from its genomic RNA and several cellular and viral proteins including the viral protein R (Vpr). Vpr participates in proviral integration into the host genome ([@B18]; [@B65]). MRJ-L facilitates nuclear localization of the HIV-1 pre-integration complex via its direct interaction with Vpr ([@B18]). As compared to MRJ-L, MRJ-S displays a relatively weak activity in nuclear localization of Vpr/Vpx likely due to its lack of the C-terminal NLS of MRJ-L ([@B17]; [@B18]). Notably, mutations in the HPD motif of MRJ-L disrupt the activity of MRJ-L in facilitating Vpx (or HIV) nuclear import, indicating the involvement of Hsp70 ([@B17]). Analogously, MRJ-L assists nuclear import of the HIV-2 viral protein X (Vpx), the paralog of HIV-1 Vpr. Depletion of MRJ-L restricts HIV-2 replication due to reduced nuclear import of the PIC ([@B17]). On the other hand, overexpression of MRJ-S suppresses HIV proviral transcription and hence compromises HIV-1 production ([@B85]). These observations together suggest that a higher L/S ratio of MRJ may promote HIV infection ([Figure 1C](#F1){ref-type="fig"}, HIV). A cohort study reveals that HIV-infected individuals indeed exhibit a slightly higher level of MRJ-L in macrophages than healthy subjects ([@B18]), supporting the positive role of MRJ-L in HIV-1 infection. It is speculated that *cis*-element polymorphisms of *MRJ* that favor L isoform expression may increase the probability of HIV infection ([@B44]). Therefore, the MRJ-L level difference between individuals may predict HIV susceptibility. On the other hand, the negative regulatory factor (Nef) of HIV facilitates nuclear translocation of Hsp40, which subsequently facilitates viral gene expression. Nevertheless, Hsp70 can counteract the nuclear import of Vpr-mediated PIC complex and hence inhibits viral replication ([@B35]).

Human Cytomegalovirus (HCMV) {#S6.SS2}
----------------------------

Human cytomegalovirus is a common opportunistic pathogen that may establish long-life latency without any symptoms in healthy individuals but may threaten immunocompromised individuals and neonates ([@B43]). HCMV has the largest genome among the human herpesviruses and replicates in the nucleus of cells. The HCMV DNA-dependent RNA polymerase, i.e., the primase UL70, forms the helicase-primase complex with UL102/105 to synthesize short RNA primers for viral DNA replication ([@B54]). MRJ-L interacts with UL70 through a fragment containing the G/F-rich region and facilitates nuclear entry of UL70, thereby promoting viral DNA synthesis ([Figure 1C](#F1){ref-type="fig"}, HCMV). On the other hand, MRJ-S is co-localized with the primase in the cytoplasm that reduces viral genome expression and synthesis ([@B64]). Thus, MRJ isoforms differentially modulate HCMV replication. Reduction of the MRJ-L expression level conceivably inhibits viral lytic infection and can be used as an anti-HCMV strategy ([@B10]).

Respiratory Syncytial Virus (RSV) {#S6.SS3}
---------------------------------

Human RSV causes lower respiratory tract infection in infants and children worldwide. RSV infection shows a higher risk of mortality compared to seasonal influenza infection in elder individuals ([@B46]). RSV belongs to the Paramyxoviridae family, consisting of a negative-sense single-stranded RNA genome that replicates in the host cytoplasm. The viral RNA-dependent RNA polymerase is responsible for both viral transcription and replication ([@B61]). Intriguingly, knockdown of MRJ-L reduces viral mRNA and protein expression and virion production, while depletion of MRJ-S has no such effects ([@B44]), indicating the critical role of MRJ-L in RSV propagation. Nevertheless, whether MRJ-L interferes with the RNA polymerase activity of RSV remains to be determined. Additionally, whether the nuclear localization property of MRJ-L is required for RSV viral production also remains puzzling ([Figure 1C](#F1){ref-type="fig"}, RSV). If this were the case, it would be interesting to elucidate why an RNA virus, which completes its life cycle in the cytoplasm, requires the nuclear function(s) of MRJ-L for propagation.

Dengue Virus (DENV) {#S6.SS4}
-------------------

Dengue virus is a mosquito-transmitted pathogen and its infection may cause haemorrhagic fever ([@B12]; [@B8]). DENV is a member of the Flaviviridae family with a positive-sense single-stranded RNA genome. Viral genome replication and package solely occur in the host cytoplasm. DENV infection induces autophagy that targets cellular lipid droplets (LDs), which are endoplasmic reticulum-derived storage organelles of neutral lipids, and hence stimulates lipid metabolism ([@B68]). On the other hand, LDs are essential for DENV production. During virion assembly, the DENV capsid protein binds to an LD surface protein and forms the nucleocapsids with viral genomes in the endoplasmic reticulum ([@B70]; [@B32]). HSPs participate in multiple steps in the DENV life cycle ([@B79]). Among them, MRJ-S is colocalized with the capsid protein on LDs and aids viral particle assembly ([@B79]; [Figure 1C](#F1){ref-type="fig"}, DENV). Depletion of MRJ-S impairs viral RNA replication and virion production ([@B79]). MRJ-S with mutations in the HPD motif fails to rescue viral production in MRJ-S-depleted cells, indicating the cooperative role of MRJ-S and Hsp70 in viral particle biogenesis. Nevertheless, MRJ-L is not engaged in the process of DENV propagation ([@B79]).

Targeting MRJ as an Antiviral Strategy {#S7}
======================================

Antisense morpholino oligonucleotides targeting viral RNAs or host mRNAs that encode proteins essential for viral propagation have been designed for treatment of viral infection ([@B87]). For example, a splice switching morpholino oligonucleotide can restrict influenza viral replication by suppressing exon inclusion of the host *transmembrane serine protease 2 (TMPRSS2)* ([@B11]). In light of the findings that MRJ is involved in viral propagation, it is possible to interfere with viral infection by targeting MRJ or modulating its splice isoform expression. Depletion of *MRJ-L* by siRNAs inhibits viral life cycles of HCMV and HIV ([@B17]; [@B64]). Our recent report shows that a morpholino oligonucleotide complementary to the 5' splice site of *MRJ* intron 8 efficiently inhibits *MRJ-L* expression *in vitro* ([@B44]). This morpholino disrupts the propagation of both pesudotyped and native HIV-1 in macrophage-like cells, and also effectively restricts subgenomic synthesis of RSV ([@B44]). It is likewise possible that masking the polyadenylation signal in intron 8 can suppress *MRJ-S* production. Since flaviviruses share a similar viral processing mechanism in LDs, it would be interesting to know whether MRJ-S-targeting agents may have a broad-spectrum antiviral effect. Since small molecule splicing modulators developed recently demonstrate their therapeutic potentials ([@B6]), it is worthy to evaluate whether any of them could influence MRJ isoform ratios, and hence impact viral infection. As described above, MRJ acts as an efficient suppressor of polyglutamine aggregation ([@B19]). Therefore, harnessing the expression or chaperone activity of MRJ would be used for treatment of neurodegenerative disorders. Together, MRJ holds a great potential as drug targets.

Conclusion {#S8}
==========

It has been demonstrated that single nucleotide polymorphisms near splice sites or polyadenylation sites of MRJ affect its isoform expression ratio ([@B44]). Thus, individuals may vary their susceptibility to viral infection, cancer or other disorders. Although the chaperone activity of MRJ is likely important for protein proteostasis, particularly disease-causing proteins, it is yet unclear whether this activity is critical for its various functions in viral infection. Nevertheless, the importance of the MRJ HPD motif in supporting HIV and dengue viral production suggests that the ATPase activity of Hsp70 contributes to viral propagation. Identification of small molecule compounds that selectively target HSPs has the values in prevention and treatment of viral infection. It has been demonstrated that Hsp70 inhibitors exert substantial antiviral activities against DENV as well as other flaviviruses ([@B79], [@B80]). Small molecules targeting different domains of Hsp90 or interfering with its cochaperone or substrate protein binding have also shown the potential in therapeutic treatment of cancer or neurodegenerative disorders ([@B76]). However, pharmacologically manipulating the activity of Hsp40 is not yet available. Therefore, to have a better understanding of the isoform expression and domain structure-function relations of MRJ would be important for drug design toward viral infection.
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